Senior Manager, Benchtop IT Systems – Devens Cell Therapy Facility at Bristol-Myers Squibb

Devens, Massachusetts, United States

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

  • Bachelor’s Degree (or higher) in Computer Science, Engineering, Life Sciences, or related field
  • 7+ years of experience managing laboratory IT systems in a GMP or GxP-regulated pharmaceutical manufacturing or research environment
  • Deep knowledge of laboratory informatics systems (e.g., LIMS, CDS, SDMS, ELN) and corresponding validation requirements
  • Demonstrated experience leading complex IT or digital projects, preferably in biologics or cell therapy manufacturing
  • Strong understanding of CSV (computer system validation), data integrity, and regulatory requirements in laboratory environments
  • Proven leadership, people management, and cross-functional project management skills
  • Excellent communication, organizational, and stakeholder management abilities
  • Advanced Degree (MS, PhD, or MBA) in a relevant discipline (preferred)
  • Experience delivering IT solutions for advanced therapy manufacturing (preferred)

Responsibilities

  • Lead and manage the end-to-end lifecycle of benchtop and laboratory IT systems (LIMS, CDS, SDMS, ELN, bespoke instrument software) within the Cell Therapy Facility, including requirements gathering, design, implementation, validation, and ongoing support
  • Oversee system integration with manufacturing, quality, and enterprise platforms, ensuring seamless data flow and strong information security
  • Ensure strict adherence to GxP, FDA, and other applicable regulatory standards in system implementation, validation, and operations
  • Partner with internal stakeholders (lab users, engineers, QA, manufacturing) to clarify user needs, recommend scalable solutions, and drive digital innovation at the bench level
  • Direct vendor relationships and manage contractors supporting laboratory IT systems, including service level agreements and performance monitoring
  • Monitor system performance and proactively resolve incidents, collaborating closely with global support teams
  • Develop and maintain robust documentation, validation plans, SOPs, and change control records for laboratory IT systems
  • Drive continuous improvement initiatives, including system upgrades, user training, cybersecurity enhancements, and lifecycle planning
  • Effectively manage operational budgets, resources, and schedules, tracking and reporting progress to site leadership and global IT function
  • Provide leadership, coaching, and mentorship to direct reports and cross-functional project teams

Skills

LIMS
CDS
SDMS
ELN
GxP
System Integration
Validation
Laboratory Automation
IT Lifecycle Management

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI